Published in Pediatr Nephrol on April 25, 2007
Fibronectins: multifunctional modular glycoproteins. J Cell Biol (1982) 8.05
The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am (1987) 7.63
Three different fibronectin mRNAs arise by alternative splicing within the coding region. Cell (1983) 6.27
Medical versus surgical treatment of primary vesicoureteral reflux: report of the International Reflux Study Committee. Pediatrics (1981) 2.53
Plasma fibronectin is synthesized and secreted by hepatocytes. J Biol Chem (1983) 2.25
Ten-year results of randomized treatment of children with severe vesicoureteral reflux. Final report of the International Reflux Study in Children. Pediatr Nephrol (2006) 2.02
Renal mRNA levels as prognostic tools in kidney diseases. J Am Soc Nephrol (2003) 1.49
What is the normal prevalence of vesicoureteral reflux? Pediatr Radiol (2000) 1.46
Primary vesicoureteric reflux as a predictor of renal damage in children hospitalized with urinary tract infection: a systematic review and meta-analysis. J Am Soc Nephrol (2003) 1.37
Proximal tubular cells promote fibrogenesis by TGF-beta1-mediated induction of peritubular myofibroblasts. Kidney Int (2002) 1.24
Relationship between acute pyelonephritis, renal scarring, and vesicoureteral reflux. Results of a coordinated research project. Pediatr Nephrol (2004) 1.16
Familial glomerulonephritis characterized by massive deposits of fibronectin. Am J Kidney Dis (1995) 1.12
Fibronectin: a brief overview of its structure, function, and physiology. Rev Infect Dis (1988) 1.07
Predictive factors of chronic kidney disease in severe vesicoureteral reflux. Pediatr Nephrol (2006) 0.99
Cellular fibronectin in patients with transitional cell carcinoma of the bladder. Urol Res (2002) 0.89
Immunohistochemical studies of reflux nephropathy. The role of extracellular matrix, membrane attack complex, and immune cells in glomerular sclerosis. Am J Pathol (1987) 0.85
Quantitative changes in the glomerular basement membrane components in human membranous nephropathy. J Pathol (1997) 0.85
Association of transforming growth factor-beta1 gene polymorphism with reflux nephropathy. J Urol (2005) 0.82
Diagnosis of bladder cancer by analysis of urinary fibronectin. Urology (2005) 0.81
Intermittent pressure-loading increases transforming growth factor-beta-1 secretion from renal tubular epithelial cells: in vitro vesicoureteral reflux model. Urol Int (2005) 0.80
Up-regulation of angiotensin-converting enzyme (ACE) gene expression induces tubulointerstitial injury in reflux nephropathy. Pediatr Surg Int (2002) 0.80
Monocyte adhesion to mesangial matrix modulates cytokine and metalloproteinase production. Kidney Int (2003) 0.79
Functional bladder capacity and urine osmolality in children with primary monosymptomatic nocturnal enuresis. Scand J Urol Nephrol (2005) 0.79
Early morning urine osmolality in nonenuretic and enuretic children. Pediatr Nephrol (1996) 0.78
[Immunohistochemical analysis of extracellular components on the glomerular sclerosis in patients with glomerulonephritis and diabetic nephropathy]. Nihon Jinzo Gakkai Shi (1989) 0.77
Increased expression of mast cells in reflux nephropathy. Pediatr Nephrol (2003) 0.77
[Fibronectin levels in blood, urine and kidney in children with kidney diseases]. Arkh Patol (1993) 0.77
Origin of urinary fibronectin. Lab Invest (1993) 0.77
Extracellular actin impairs glomerular capillary repair in experimental mesangioproliferative glomerulonephritis. Nephron Exp Nephrol (2003) 0.77
Analysis of collagen IV and fibronectin in blood and urine in evaluation of nephrotic fibrosis in children with chronic glomerulonephritis. Med Sci Monit (2002) 0.77
Clinical significance of urinary interleukin-6 in children with reflux nephropathy. J Urol (2001) 0.76
Hematological parameters in adolescents with hyperuricemia. Indian Pediatr (2014) 2.00
Assessment of lithogenic risk in children based on a morning spot urine sample. J Urol (2010) 1.45
Polish 2010 growth references for school-aged children and adolescents. Eur J Pediatr (2010) 1.40
KIM-1 and NGAL: new markers of obstructive nephropathy. Pediatr Nephrol (2011) 1.23
Genetic screening in adolescents with steroid-resistant nephrotic syndrome. Kidney Int (2013) 1.21
Neutrophil gelatinase-associated lipocalin (NGAL): a new marker of cyclosporine nephrotoxicity? Pediatr Nephrol (2010) 1.11
Perception of health-related quality of life in children with chronic kidney disease by the patients and their caregivers: multicentre national study results. Qual Life Res (2013) 0.94
A new approach to the diagnosis of children's urolithiasis based on the Bonn Risk Index. Pediatr Nephrol (2008) 0.92
Hypertension in dialysed children: the prevalence and therapeutic approach in Poland--a nationwide survey. Nephrol Dial Transplant (2005) 0.91
MDR-1 gene polymorphisms and clinical course of steroid-responsive nephrotic syndrome in children. Pediatr Nephrol (2006) 0.90
Normative data on the Bonn Risk Index for calcium oxalate crystallization in healthy children. Pediatr Nephrol (2007) 0.89
Perivascular epithelioid tumor (PEComa) of the falciform/ broad ligament. Pol J Pathol (2008) 0.87
Effect of cyclosporin A on proteinuria in the course of glomerulopathy associated with WT1 mutations. Eur J Pediatr (2010) 0.86
Does obesity or hyperuricemia influence lithogenic risk profile in children with urolithiasis? Pediatr Nephrol (2014) 0.86
Urinary cytokine profiles in unilateral congenital hydronephrosis. Pediatr Nephrol (2012) 0.84
[Assessment of oxalate concentration in serum and urine of children with renal stones]. Wiad Lek (2005) 0.84
Characterization of 28 novel patients expands the mutational and phenotypic spectrum of Lowe syndrome. Pediatr Nephrol (2014) 0.83
Response to prednisone in relation to NR3C1 intron B polymorphisms in childhood nephrotic syndrome. Pediatr Nephrol (2008) 0.81
Serum RANKL, osteoprotegerin (OPG), and RANKL/OPG ratio in nephrotic children. Pediatr Nephrol (2010) 0.81
Urinary monocyte chemoattractant protein-1 excretion in children with glomerular proteinuria. Scand J Urol Nephrol (2010) 0.81
Urinary angiotensinogen as a marker of intrarenal angiotensin II activity in adolescents with primary hypertension. Pediatr Nephrol (2013) 0.81
Evaluation of bladder instability in children with recurrent urinary tract infections. Med Sci Monit (2002) 0.81
Assessment of serum cystatin C in children with congenital solitary kidney. Pediatr Nephrol (2006) 0.81
Urinary angiotensinogen as a novel marker of obstructive nephropathy in children. Acta Paediatr (2013) 0.80
Correspondence between Ca²⁺ and calciuria, citrate level and pH of urine in pediatric urolithiasis. Pediatr Nephrol (2013) 0.80
Expression of glucocorticoid receptors in mononuclear cells in nephrotic syndrome. Pediatr Nephrol (2003) 0.80
A potential pathogenic role of oxalate in autism. Eur J Paediatr Neurol (2011) 0.80
Relationship between serum IgA/C3 ratio and severity of histological lesions using the Oxford classification in children with IgA nephropathy. Pediatr Nephrol (2014) 0.79
Functional bladder capacity and urine osmolality in children with primary monosymptomatic nocturnal enuresis. Scand J Urol Nephrol (2005) 0.79
Expression of P-glycoprotein in lymphocytes from children with nephrotic syndrome, depending on their steroid response. Pediatr Nephrol (2006) 0.79
Osteopontin and symmetric dimethylarginine plasma levels in solitary functioning kidney in children. Acta Paediatr (2012) 0.79
Epidemiological study of acute poisoning in children: a 5-year retrospective study in the Paediatric University Hospital in Białystok, Poland. Emerg Med J (2012) 0.79
Paediatric normative data for urine NGAL/creatinine ratio. Acta Paediatr (2013) 0.78
Psychosocial aspects of children and families of children treated with automated peritoneal dialysis. Pediatr Nephrol (2013) 0.78
Is plasma symmetric dimethylarginine a suitable marker of renal function in children and adolescents? Scand J Urol Nephrol (2011) 0.78
A need to establish normative data for plasma oxalates. Am J Kidney Dis (2008) 0.78
Glucocorticoid receptor and vascular endothelial growth factor in nephrotic syndrome. Acta Paediatr (2006) 0.78
Reference values of plasma oxalate in children and adolescents. Pediatr Nephrol (2008) 0.78
Mutational analysis in podocin-associated hereditary nephrotic syndrome in Polish patients: founder effect in the Kashubian population. J Appl Genet (2013) 0.78
Serum 25-hydroxyvitamin D, osteocalcin, and parathormone status in children with meningomyelocele. Neuropediatrics (2012) 0.77
Urine NGAL and KIM-1 in children and adolescents with hyperuricemia. Pediatr Nephrol (2013) 0.77
Glutathione reductase activity correlates with concentration of extracellular matrix degradation products in synovial fluid from patients with joint diseases. Acta Biochim Pol (2009) 0.77
[WT1 mutation as a cause of progressive nephropathy in Frasier syndrome--case report]. Pol Merkur Lekarski (2009) 0.77
Urinary nerve growth factor level in children with neurogenic bladder due to myelomeningocele. Scand J Urol (2013) 0.77
Serum copeptin levels in adolescents with primary hypertension. Pediatr Nephrol (2013) 0.77
[Serum and urinary homocysteine in children with steroid-dependent nephrotic syndrome]. Pol Merkur Lekarski (2011) 0.77
Urinary transforming growth factor beta1 in children and adolescents with congenital solitary kidney. Pediatr Nephrol (2008) 0.76
Laminin and transforming growth factor beta-1 in children with vesicoureteric reflux. Pediatr Nephrol (2008) 0.76
[Chronic peritoneal dialysis in infants--preliminary results of the multicenter survey]. Przegl Lek (2006) 0.76
Is symmetric dimethylarginine a sensitive biomarker of subclinical kidney injury in children born with low birth weight? Biomarkers (2014) 0.76
[FGF23 and Klotho protein--the role in the pathogenesis of hypertension]. Wiad Lek (2015) 0.76
Urine fibroblast growth factor 23 levels in hypertensive children and adolescents. Croat Med J (2015) 0.76
Serum and urine leptin concentration in children with nephrotic syndrome. Pediatr Nephrol (2005) 0.75
High-sensitivity C-reactive protein (hs-CRP) level in children with nephrotic syndrome. Pediatr Nephrol (2006) 0.75
Expression of glucocorticoid receptors in nephrotic children depending on total prednisone dose. J Pediatr Endocrinol Metab (2005) 0.75
Normal values for urine renalase excretion in children. Pediatr Nephrol (2014) 0.75
New tubular injury markers in children with a solitary functioning kidney. Pediatr Nephrol (2014) 0.75
Is the serum level of salusin-β associated with hypertension and atherosclerosis in the pediatric population? Pediatr Nephrol (2014) 0.75
Urinary citrate excretion in healthy children depends on age and gender. Pediatr Nephrol (2014) 0.75
Evaluation of Serum Uric Acid: Authors' Reply. Indian Pediatr (2015) 0.75
Anxiety in children and adolescents with chronic kidney disease--multicenter national study results. Kidney Blood Press Res (2013) 0.75
Urinary MMP-9/NGAL ratio as a potential marker of FSGS in nephrotic children. Dis Markers (2013) 0.75
Asymmetric and symmetric dimethylarginine in adolescents with hyperuricemia. Dis Markers (2013) 0.75
The effects of breastfeeding on serum asymmetric dimethylarginine levels and body composition in children. Breastfeed Med (2014) 0.75
[Assessment of 24-hour blood pressure function of the single kidney in children with renal agenesis]. Pol Merkur Lekarski (2005) 0.75
[Role of matrix metalloproteinases (MMP) and their tissue inhibitors (TIMP) in nephrology]. Przegl Lek (2009) 0.75
Spontaneous urinary calcium oxalate crystallization in hypercalciuric children. Pediatr Nephrol (2009) 0.75
Expression of multidrug resistance P-glycoprotein on lymphocytes from nephrotic children treated with cyclosporine A and ACE-inhibitor. Eur J Pediatr (2006) 0.75
[Serum cystatin C concentration in children with urinary stones]. Pol Merkur Lekarski (2006) 0.75
[Reference values of 24-hour ambulatory blood pressure in healthy children by height]. Pol Merkur Lekarski (2004) 0.75
[The evaluation of urinary tract dysfunction in children with monosymptomatic primary nocturnal enuresis]. Pol Merkur Lekarski (2008) 0.75
Vascular endothelial growth factor in children with nephrotic syndrome treated with cyclosporine A. Acta Paediatr (2006) 0.75
Urodynamic Findings and Renal Function in Children with Neurogenic Bladder after Myelomeningocele. Urol Int (2015) 0.75
[The concentration of plasma anion oxalate in children treatment antibiotics beta lactame]. Pol Merkur Lekarski (2006) 0.75
[The effect of cyclosporine A in steroid-dependent nephrotic syndrome in children]. Pol Merkur Lekarski (2005) 0.75
[Assessment of transforming growth factor-beta1 in serum of children with idiopathic nephrotic syndrome depending on the way of treatment]. Pol Merkur Lekarski (2003) 0.75
[Vasculitis of cerebral vessels, probable cause of neurological complications in a child with Schonlein-Henoch purpura]. Pol Merkur Lekarski (2002) 0.75
[Serum and urinary concentration of selected metalloproteinases and their tissue inhibitors in children with vesicoureteral reflux]. Pol Merkur Lekarski (2010) 0.75
[Urinary TGF-beta1 excretion in children with renal cysts]. Przegl Lek (2006) 0.75
[Analysis of vesicoureteral reflux (VUR) course in children]. Pol Merkur Lekarski (2008) 0.75
[Assessment of fructose-1,6-biphosphatase in urine of children with acute pyelonephritis]. Pol Merkur Lekarski (2004) 0.75
[Evaluation of inflammatory and renal injury markers in youngest children with pyelonephritis]. Pol Merkur Lekarski (2008) 0.75
[Matrix metalloproteinases 2 and 9 and their tissue inhibitors 1 and 2 in the urine of children with pyelonephritis]. Pol Merkur Lekarski (2009) 0.75
High-sensitivity C-reactive protein and mean platelet volume in paediatric hypertension. Pediatr Nephrol (2010) 0.75